Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
SmarterDx, an AI startup specializing in clinical review and quality audits for medical claims, has closed a $50 million Series B funding round. This funding round was led by Transform Capital, with continued support from Bessemer Venture Partners, Flare Capital, Floodgate Fund, and Virtue VC. The new investment brings SmarterDx's total funding to $71 million. The company's growth trajectory has been remarkable, with a previous $5 million Seed round in 2022. SmarterDx's clinical AI is designed to increase hospital revenues through improved clinical documentation integrity (CDI) and quality reporting.
SmarterDx — an AI startup that provides clinical review and quality audits for medical claims — closed a $50 million Series B funding round, bringing its total funding to date to $71 million. https://t.co/d5Gfw4RLCl
🎉 We are thrilled to announce our $50 million Series B! This funding round was led by @transformcptl, with continued support from @BessemerVP, @FlareCapital and @floodgatefund: https://t.co/b1ljcfMPna https://t.co/3G4GxefL8m
Truly a standout RCM business — SmarterDx is changing the mid-RCM landscape and setting a new standard for hospitals and health systems. Congrats on your $50M Series B guys! Check out more here https://t.co/09gLVghmSH https://t.co/BB1pgLW03c
